Richard Paul Bryce's Net Worth

$5 Million

Estimate Recalculated Jul 24, 2024 05:28PM EST

Who is Richard Paul Bryce?

Richard Paul Bryce has an estimated net worth of $5 Million. This is based on reported shares across multiple companies, which include PUMA BIOTECHNOLOGY, INC., Rain Oncology Inc., and enGene Holdings Inc..

SEC CIK

Richard Paul Bryce's CIK is 0001553037

Past Insider Trading and Trends

2017 was Richard Paul Bryce's most active year for acquiring shares with 5 total transactions. Richard Paul Bryce's most active month to acquire stocks was the month of January. 2019 was Richard Paul Bryce's most active year for disposing of shares, totalling 14 transactions. Richard Paul Bryce's most active month to dispose stocks was the month of June. 2017 saw Richard Paul Bryce paying a total of $395,500.00 for 66,500 shares, this is the most they've acquired in one year. In 2017 Richard Paul Bryce cashed out on 74,291 shares for a total of $4,001,885.35, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

PUMA BIOTECHNOLOGY, INC. (PBYI) Snapshot price: $5.04

SEE REMARKS

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-0.35%
-426.00
$9.80
-$4,176.04
121.66K
Apr 5
Form 4
-0.34%
-422.00
$10.15
-$4,283.30
122.09K
Mar 2
Form 4
+75.86%
52.85K
—
—
122.51K
Feb 17
Form 4
-0.59%
-415.00
$12.23
-$5,075.95
69.66K
Feb 2
Form 4
-8.55%
-6.55K
$10.23
-$67,016.16
70.08K
Jan 4
Form 4
-0.12%
-92.00
$11.65
-$1,071.80
76.63K
Dec 2
Form 4
-0.13%
-97.00
$7.81
-$757.57
76.72K
Nov 2
Form 4
-0.12%
-91.00
$10.14
-$923.10
76.82K
Oct 2
Form 4
-0.12%
-90.00
$9.77
-$879.30
76.91K
Sep 2
Form 4
-0.11%
-86.00
$10.80
-$928.80
77K
Aug 3
Form 4
-0.85%
-660.00
$10.67
-$7,040.42
77.08K
Jul 2
Form 4
-0.11%
-89.00
$10.66
-$948.74
77.74K
Jun 2
Form 4
-0.11%
-89.00
$9.62
-$856.19
77.83K
May 4
Form 4
-0.12%
-91.00
$7.37
-$670.68
77.92K
Apr 2
Form 4
-0.12%
-96.00
$10.02
-$962.15
78.01K
Mar 2
Form 4
+124.23%
43.27K
—
—
78.11K
Feb 11
Form 4
-0.30%
-105.00
$8.02
-$841.57
34.83K
Feb 3
Form 4
-4.16%
-1.52K
$8.40
-$12,734.32
34.94K
Jan 2
Form 4
-0.23%
-83.00
$10.34
-$858.23
36.45K
Dec 2
Form 4
-0.24%
-88.00
$7.38
-$649.45
36.54K
Nov 4
Form 4
-0.25%
-91.00
$10.05
-$914.55
36.63K
Oct 2
Form 4
-0.26%
-95.00
$10.11
-$960.45
36.72K
Sep 4
Form 4
-0.25%
-94.00
$9.00
-$846.00
36.81K
Aug 2
Form 4
-4.75%
-1.84K
$10.10
-$18,588.76
36.91K
Scheduled
Jul 22
Form 4
-0.23%
-89.00
$12.78
-$1,137.42
38.75K
Jul 2
Form 4
-0.23%
-88.00
$15.07
-$1,326.16
38.84K
Jun 3
Form 4
-0.22%
-85.00
$32.38
-$2,752.31
38.92K
May 2
Form 4
-0.23%
-88.00
$35.78
-$3,148.65
39.01K
Apr 2
Form 4
-0.22%
-88.00
$38.66
-$3,402.08
39.1K
Mar 4
Form 4
+33.81%
9.9K
—
—
39.19K
Feb 6
Form 4
-0.30%
-89.00
$27.77
-$2,471.53
29.29K
Feb 4
Form 4
-6.25%
-1.96K
$24.72
-$48,426.48
29.37K
Scheduled
Jan 22
Form 4
-3.72%
-1.21K
$20.67
-$25,010.70
31.33K
Jan 3
Form 4
-5.34%
-1.84K
$51.95
-$95,381.30
32.54K
Scheduled
Jul 20
Form 4/A
+35.46%
9K
—
—
34.38K
Feb 11
Form 4
-20.75%
-9.00K
—
—
34.38K
Feb 11
Form 4
-6.83%
-1.86K
$92.75
-$172,515.00
25.38K
Scheduled
Jan 22
Form 4
—
0
$65.65
-$1,630,500.00
27.24K
Scheduled
Sep 29
Form 4
—
0
$55.70
-$1,331,900.00
27.24K
Scheduled
Sep 6 - Sep 7
Form 4
-6.83%
-2.00K
$94.48
-$188,777.28
27.24K
Scheduled
Jul 20
Form 4
—
0
$49.20
-$379,000.00
29.24K
Scheduled
Jul 3
Form 4
—
0
—
—
0
Feb 16
Form 4
-7.27%
-2.29K
$33.24
-$76,208.08
29.24K
Scheduled
Jan 20
Form 4
+105,000.00%
31.5K
—
—
31.53K
Oct 14
Form 4
—
0
—
—
0
May 25
Form 4
—
0
—
—
0
Aug 3
Form 4
—
0
$60.67
-$296,184.00
30
Scheduled
Jul 6
Form 4
∞
30
$82.81
$2,484.42
30
Apr 9 - Apr 11
Form 4
—
0
—
—
0
Jul 9
Form 4
—
0
—
—
0
Jul 9
Form 4
—
0
—
—
0
Jun 26
Form 3
—
0
—
—
0
No matching records found

Rain Oncology Inc. (RAIN) No price found

Chief Medical Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Feb 15
Form 4
—
0
—
—
0
Jan 7
Form 3
—
0
—
—
0
No matching records found

enGene Holdings Inc. (ENGN) Snapshot price: $7.853

Chief Medical Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Nov 30
Form 3
—
0
—
—
0
No matching records found